Pharmicell Co., Ltd. (KRX:005690)
South Korea · Delayed Price · Currency is KRW 9,500.00
+100.00 (1.06%)
Nov 2, 2026, 3:30 PM KST
Pharmicell Market Cap
Pharmicell has a market cap or net worth of 570.04 billion as of October 30, 2026. It is the 15,464th most valuable company in the world and the 412th biggest in South Korea. Its market cap has decreased by 44.02% in one year.
Market Cap
570.04B
Enterprise Value
n/a
Revenue
23.94B
Global Rank
Country Rank
#412 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since August 29, 1995, Pharmicell's market cap has increased from 40.96B to 570.04B, an increase of 1,291.70%. That is a compound annual growth rate of 8.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 570.04B | -34.62% |
| Dec 30, 2025 | 871.86B | 75.48% |
| Dec 30, 2024 | 496.83B | 36.41% |
| Dec 28, 2023 | 364.22B | -46.28% |
| Dec 29, 2022 | 678.05B | -13.33% |
| Dec 30, 2021 | 782.30B | -24.57% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Komipharm International | 651.95B |
| Chabiotech | 624.39B |
| Proteina | 599.21B |
| Onconic Therapeutics | 549.89B |
| Hyundai Bioscience | 518.22B |
| GI Innovation | 434.19B |
| GC Corp. | 415.33B |
| Medy-Tox | 412.68B |